The Cognitive Age heralds a fundamental shift from analog to digital to cognitive processes, integrating AI with human expertise across sectors like healthcare, education, and industry. This symbiosis of human and machine intelligence is reshaping our world, enhancing decision-making and driving innovation to solve our most complex challenges.
Artificial Intelligence (AI) is reshaping the way we assess health technologies, from predictive modeling and economic evaluations to the simulation of real-world patient data. This session explores how AI is enhancing decision-making and improving patient experiences within the realm of health technology assessment (HTA), painting a comprehensive picture of AI's potential and the challenges it faces in transforming the HTA landscape.
Digital health is transforming healthcare by empowering patients, streamlining data collection, and driving innovation. This session delves into the vast opportunities and challenges within the digital health landscape, focusing on HTA, patient involvement in evidence generation, and the potential of digital therapeutics to improve health equity.
Don't miss the Center’s interactive poster session to explore cutting-edge research driving value-based healthcare. Interact with Center researchers and gain insights into their latest findings.
Join us for a sneak peek into the Center’s upcoming Blueprint for Patient-Centered Value Research, showcasing how we apply our principles to advance the science and practice of patient-centered value research. Scheduled for release in 2025, this Blueprint will equip stakeholders with a model to prioritize patients in their research practices.
The advent of targeted and curative therapies, especially in cell and gene therapy, necessitates a shift in how we determine and pay for value. This session will delve into the innovative financing mechanisms that are reshaping access and affordability in healthcare. We'll explore successful current models and new, cutting-edge paradigms to address payment challenges.
This session will feature expert panelists debating pressing health policy issues such as the Inflation Reduction Act of 2022 (IRA) and Medicare Drug Price Negotiation Program (DPNP) implementation, the 2024 election, HTA feasibility in the US, and the government's role in drug pricing. Gain insights into diverse perspectives and explore future implications of these critical policy issues.